Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eterna Therapeutics Inc.

0.2160
+0.01115.42%
Post-market: 0.2061-0.0099-4.58%17:59 EDT
Volume:210.79K
Turnover:43.59K
Market Cap:13.43M
PE:-0.07
High:0.2200
Open:0.2040
Low:0.1900
Close:0.2049
Loading ...

Company Profile

Company Name:
Eterna Therapeutics Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
6
Office Location:
1035 Cambridge Street,Suite 18A,Cambridge,Massachusetts,United States
Zip Code:
02141
Fax:
- -
Introduction:
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Directors

Name
Position
James Bristol
Chairman of the Board
Sanjeev Luther
President and Chief Executive Officer and Director
Dorothy Clarke
General Counsel and Director
Peter Cicala
Director
William Wexler
Director

Shareholders

Name
Position
Sanjeev Luther
President and Chief Executive Officer and Director
Sandra Gurrola
Senior Vice President, Finance